Nuwellis (NUWE) Net Income towards Common Stockholders (2011 - 2026)
Nuwellis posted quarterly Net Income towards Common Stockholders of -$4.5 million for Q1 2026, down 50.65% year-on-year from -$9.2 million in Q1 2025, and down 87.48% on a QoQ basis from -$2.4 million in Q4 2025.
Nuwellis (NUWE) has 16 years of Net Income towards Common Stockholders data on file, last reported at -$4.5 million in Q1 2026.
- For the quarter ending Q1 2026, Net Income towards Common Stockholders fell 50.65% year-over-year to -$4.5 million; the trailing twelve-month figure through Mar 2026 stood at -$19.0 million (down 93.37% YoY), and the FY2025 full-year result was -$17.5 million, down 64.88% from the prior year.
- Net Income towards Common Stockholders for Q1 2026 stood at -$4.5 million, down from -$2.4 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at $12.7 million in Q4 2022 and bottomed at -$12.6 million in Q2 2025.
- The 5-year median for Net Income towards Common Stockholders is -$3.9 million (2022), against an average of -$3.3 million.
- The widest annual swing landed in 2023, when Net Income towards Common Stockholders slumped 162.59%; it then surged 169.97% in 2024.
- A 5-year view of Net Income towards Common Stockholders shows it stood at $12.7 million in 2022, then slumped by 162.59% to -$7.9 million in 2023, then jumped by 81.48% to -$1.5 million in 2024, then plunged by 64.92% to -$2.4 million in 2025, then tumbled by 87.48% to -$4.5 million in 2026.
- The last three Net Income towards Common Stockholders figures came in at -$4.5 million (Q1 2026), -$2.4 million (Q4 2025), and $469000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 187,319.30 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Nuwellis | 1.45 Mn | -630,292.49 | 1.68 Mn | -4.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.54 Mn |
| Dec 31, 2025 | -2.42 Mn |
| Sep 30, 2025 | 469,000.00 |
| Jun 30, 2025 | -12.55 Mn |
| Mar 31, 2025 | -3.01 Mn |
| Dec 31, 2024 | -1.47 Mn |
| Sep 30, 2024 | 2.36 Mn |
| Jun 30, 2024 | -7.73 Mn |
| Mar 31, 2024 | -3.79 Mn |
| Dec 31, 2023 | -7.93 Mn |
| Sep 30, 2023 | -3.37 Mn |
| Jun 30, 2023 | -4.85 Mn |
| Mar 31, 2023 | -6.49 Mn |
| Dec 31, 2022 | 12.66 Mn |
| Sep 30, 2022 | -3.87 Mn |
| Jun 30, 2022 | -4.29 Mn |
| Mar 31, 2022 | -4.47 Mn |
| Dec 31, 2021 | -4.37 Mn |
| Sep 30, 2021 | -5.27 Mn |
| Jun 30, 2021 | -4.73 Mn |
| Mar 31, 2021 | -5.22 Mn |
| Dec 31, 2020 | -3.12 Mn |
| Sep 30, 2020 | -4.26 Mn |
| Jun 30, 2020 | -3.92 Mn |
| Mar 31, 2020 | -4.57 Mn |
| Dec 31, 2019 | -4.46 Mn |
| Sep 30, 2019 | -4.51 Mn |
| Jun 30, 2019 | -4.43 Mn |
| Mar 31, 2019 | -4.73 Mn |
| Dec 31, 2018 | -4.26 Mn |
| Sep 30, 2018 | -4.24 Mn |
| Jun 30, 2018 | -4.18 Mn |
| Mar 31, 2018 | -4.35 Mn |
| Dec 31, 2017 | -7.13 Mn |
| Sep 30, 2017 | -2.85 Mn |
| Jun 30, 2017 | -2.46 Mn |
| Mar 31, 2017 | -940,000.00 |
| Dec 31, 2016 | -2.90 Mn |
| Sep 30, 2016 | -3.92 Mn |
| Jun 30, 2016 | -4.19 Mn |
| Mar 31, 2016 | -4.79 Mn |
| Dec 31, 2015 | -6.60 Mn |
| Sep 30, 2015 | -6.56 Mn |
| Jun 30, 2015 | -6.36 Mn |
| Mar 31, 2015 | -7.06 Mn |
| Dec 31, 2014 | -6.74 Mn |
| Sep 30, 2014 | -6.13 Mn |
| Jun 30, 2014 | -6.38 Mn |
| Mar 31, 2014 | -6.33 Mn |
| Dec 31, 2013 | -7.10 Mn |
| Sep 30, 2013 | -6.04 Mn |
| Jun 30, 2013 | -4.22 Mn |
| Mar 31, 2013 | -4.40 Mn |
| Dec 31, 2012 | -4.07 Mn |
| Sep 30, 2012 | -3.30 Mn |
| Jun 30, 2012 | -2.62 Mn |
| Mar 31, 2012 | -4.08 Mn |
| Dec 31, 2011 | -5.24 Mn |
| Sep 30, 2011 | -4.67 Mn |
| Jun 30, 2011 | -3.47 Mn |
| Mar 31, 2011 | -2.82 Mn |